Eliaz Therapeutics Inc.

CIK 2042609 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eliaz Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Jul 7, 2026C-U0001872856-26-000237
Jun 10, 2026C0001872856-26-000220
May 4, 2026C-U0002042609-26-000003
Apr 29, 2026C-AR0001872856-26-000133
Mar 3, 2026C/A0002042609-26-000002
Dec 8, 2025C0002042609-25-000007
Nov 28, 2025C-U0002042609-25-000005
Oct 24, 2025D0001062993-25-016285
Aug 7, 2025C/A0001670254-25-000734
Jul 22, 2025C/A0001670254-25-000712
Jun 13, 2025C/A0001670254-25-000654
Apr 25, 2025C/A0001670254-25-000418
Mar 31, 2025C/A0001670254-25-000260
Mar 25, 2025C/A0001670254-25-000234
Nov 7, 2024C0001670254-24-001076